Health Care, Not Sick Care: A conversation on what changes with at-home diagnostics

​The at-home diagnostics shift isn't a forecast anymore. Regulatory approvals over the past few years opened the door to large-quantity at-home blood collection for the first time, and the infrastructure to support it at scale is now catching up. Join us for a short conversation on what that shift looks like in practice, hosted by Daymaker Ventures and featuring David Shor of Diagnostic.ly. He'll be joined by someone who spent years on the buyer side at one of the major healthcare companies using Diagnostic.ly's platform before joining the company herself. Her perspective on why the demand is real comes from having lived it, not from a sales script.

​We'll walk through how diagnostics is moving from something that happens to you in a clinic to something built into how care reaches people where they already are, and what that means for access, convenience, and outcomes. Diagnostic.ly is a Daymaker Ventures portfolio company, and this session is meant as a market briefing, not a pitch.

​This session will be recorded. By registering, you're agreeing your attendance and any questions you submit may be included in that recording.

​Agenda:

​++ Welcome and framing, Tonya J. Long, Daymaker Ventures

++ The changing story of health care convenience, David Shor, Diagnostic.ly

++ What changes for patients and providers: a conversation with someone who deeply understands the buyer side, moderated by David Shor

++ Open Q&A

++ Closing remarks, Ronak Shah, Daymaker Ventures